Profile: Diasorin SpA (DIAS.MI)
DIAS.MI on Milan Stock Exchange
29.60EUR
20 May 2013
29.60EUR
20 May 2013
Price Change (% chg)
€-0.19 (-0.64%)
€-0.19 (-0.64%)
Prev Close
€29.79
€29.79
Open
--
--
Day's High
€30.13
€30.13
Day's Low
€29.22
€29.22
Volume
530,976
530,976
Avg. Vol
258,872
258,872
52-wk High
€31.21
€31.21
52-wk Low
€19.71
€19.71
DiaSorin SpA, based in Italy, provides medical diagnostic equipment. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. Diasorin's products are based on chemiluminescence and magnetic microparticle technologies.
Company Address
Diasorin SpA
via Crescentino snc
SALUGGIA 13040
P: +390161.487526
F: +390161.487670
Company Web Links
| Name | Compensation |
|---|---|
Gustavo Denegri |
400,000 |
Carlo Rosa |
711,223 |
Antonio Boniolo |
150,000 |
Pier Luigi De Angelis |
-- |
John Eskdale |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
